Trial intelligence / Profile preview

Menactra Booster Response in Children Previously Vaccinated with Meningococcal Polysaccharide Vaccine

NCT00539032Phase 3Completed

Sponsor
Sanofi
Start
Sep 2007
Primary completion
Aug 2008
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of meningococcal A conjugate vaccine in invasive meningococcal disease (IMD), meningococcal meningitis, meningococcemia, sponsored by Sanofi. Started Sep 2007; status: completed.

02

Drugs

meningococcal A conjugate vaccine
03

Conditions

invasive meningococcal disease (IMD)meningococcal meningitismeningococcemia

Beyond the preview

Go deeper on NCT00539032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00539032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call